- Home
- ATYR vs MRT Comparison
ATYR vs MRT Comparison
Compare ATYR & MRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- MRT
- Stock Information
- Founded
- ATYR 2005
- MRT 2018
- Country
- ATYR United States
- MRT Turkey
- Employees
- ATYR N/A
- MRT N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- MRT Rental/Leasing Companies
- Sector
- ATYR Health Care
- MRT Consumer Discretionary
- Exchange
- ATYR Nasdaq
- MRT Nasdaq
- Market Cap
- ATYR 535.0M
- MRT 228.0M
- IPO Year
- ATYR 2015
- MRT N/A
- Fundamental
- Price
- ATYR $1.08
- MRT $2.46
- Analyst Decision
- ATYR Buy
- MRT Strong Buy
- Analyst Count
- ATYR 6
- MRT 2
- Target Price
- ATYR $8.88
- MRT $6.00
- AVG Volume (30 Days)
- ATYR 14.2M
- MRT 38.1K
- Earning Date
- ATYR 11-06-2025
- MRT 08-08-2018
- Dividend Yield
- ATYR N/A
- MRT N/A
- EPS Growth
- ATYR N/A
- MRT N/A
- EPS
- ATYR N/A
- MRT N/A
- Revenue
- ATYR N/A
- MRT $18,659,655.00
- Revenue This Year
- ATYR $420.85
- MRT $83.87
- Revenue Next Year
- ATYR $1,919.44
- MRT $115.34
- P/E Ratio
- ATYR N/A
- MRT N/A
- Revenue Growth
- ATYR N/A
- MRT N/A
- 52 Week Low
- ATYR $1.00
- MRT $1.77
- 52 Week High
- ATYR $7.29
- MRT $3.89
- Technical
- Relative Strength Index (RSI)
- ATYR 22.44
- MRT 48.48
- Support Level
- ATYR $1.00
- MRT $2.38
- Resistance Level
- ATYR $6.50
- MRT $2.57
- Average True Range (ATR)
- ATYR 0.46
- MRT 0.09
- MACD
- ATYR -0.42
- MRT 0.01
- Stochastic Oscillator
- ATYR 1.45
- MRT 50.23
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About MRT Marti Technologies Inc.
Marti Technologies Inc is a mobility app, offering multiple transportation services to its riders. Marti operates a ride-hailing service that matches riders with car, motorcycle, and taxi drivers, and operates a large fleet of rental e-mopeds, e-bikes, and e-scooters. All of Marti's offerings are serviced by proprietary software systems and IoT infrastructure.